The MRF's Scientific Leadership

The MRF’s Scientific Leadership is comprised of multidisciplinary experts in basic and translational research, dermatology, epidemiology, genomics, pathology, surgery and medical oncology. 
 
Members of the MRF’s Scientific Advisory Committee (SAC) are listed below. Learn more about the Scientific Steering Committee behind the MRF’s CURE OM initiative and the MRFBC's Steering Committee. To read more about the MRF’s melanoma research and science objectives, visit our Research Center
 

Co-Chairs:

Michael B. Atkins, M.D., Ph.D.

Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center
Georgetown University
Washington, D.C.
 

Ze'ev A. Ronai, Ph.D.

Professor and Scientific Director
Deputy Director, NCI Cancer Center
Sanford Burnham Medical Research Institute
La Jolla, California
 

Members:

Andrew Aplin, Ph.D.

Program Leader for Cancer Cell Biology and Signaling, Kimmel Cancer Center, Thomas Jefferson University
Thomas Jefferson University 
Philadelphia, Pennsylvania
 

Boris C. Bastian, M.D.

Professor of Dermatology and Pathology
Gerson and Barbara Bass Bakar Distinguished Professor of Cancer Biology
University of California, San Francisco 
San Francisco, California
 

Kevin Brown, Ph.D.

Investigator
Laboratory of Translational Genomics
NCI/DCEG
Bethesda, Maryland

 

Clara Curiel, M.D. 

Associate Professor of Dermatology
The University of Arizona Cancer Center
Tucson, Arizona
 

David E. Fisher, M.D., Ph.D.

Director, Melanoma Program and Chief, Department of Dermatology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts
 

Keith T. Flaherty, M.D.

Director, Developmental Therapeutics
Massachusetts General Hospital
Boston, Massachusetts
 

Alan Geller, MPH, RN

Senior Lecturer on Social and Behavioral Sciences
Department of Social and Behavioral Sciences
Harvard School of Public Health
Boston, Massachusetts
 

Jeff Gershenwald, M.D.

Professor, Department of Surgical Oncology, Division of Surgery
The University of Texas MD Anderson Cancer Center
Houston, TX
 

Ruth Halaban, Ph.D. 

Senior Research Scientist
Yale University School of Medicine
Department of Dermatology
New Haven, Connecticut
 

Dorothee Herlyn, D.V.M., D.Sc. (Grant SRO)

Professor Emeritus 
The Wistar Institute
Philadelphia, Pennsylvania
 

Meenhard Herlyn, D.V.M., D.Sc.

Professor and Program Leader, Molecular and Cellular Oncogenesis Program
The Wistar Institute
Philadelphia, Pennsylvania
 

John Kirkwood, M.D.

Professor, Department of Medicine
Co-Leader, Melanoma Program
University of Pittsburgh
Pittsburgh, Pennsylvania
 

Randy Lomax, M.A., M.F.T.

Chair Emeritus, Melanoma Research Foundation
San Francisco, California
 

Martin McMahon, Ph.D.

Assistant Director of Professional Education
Co-Leader Developmental Therapeutics Program
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California
 

Glenn Merlino, Ph.D.

Head, Cancer Modeling Section
Chief, Laboratory of Cancer Biology and Genetics
Center for Cancer Research
National Cancer Institute
Bethesda, Maryland
 

Toni Ribas, M.D., Ph.D.

Co-Leader, Research Education, Training and Career Development Program (CTSI-ED)
Professor of Medicine, Hematology-Oncology
Professor of Surgery, Surgical Oncology
Associate Director, JCCC Tumor Immunology Program Area
Professor, Molecular and Medical Pharmacology
Los Angeles, California
 

Lynn Schuchter, M.D.

Chief, Hematology/Oncology, Professor of Medicine
Leader: Melanoma Program
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania
 

Mario Sznol, M.D. 

Professor of Medicine, Medical Oncology
Clinical Research Program Leader, Melanoma Program
Co-Director, Yale SPORE in Skin Cancer
Yale Cancer Center
New Haven, Connecticut
 

Vernon K. Sondak, M.D.

Department Chair, Cutaneous Oncology
Director of Surgical Education
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
 

Jeff Sosman, M.D. 

Professor of Medicine (Hematology/Oncology)
Director, Melanoma & Tumor Immunotherapy Program
Co-Leader, VICC Signal Transduction & Cell Proliferation Research Program
Medical Oncologist at Vanderbilt-Ingram Cancer Center
Nashville, Tennessee
 

Nancy E. Thomas, M.D., Ph.D.

Associate Professor
Department of Dermatology
University of North Carolina
Chapel Hill, North Carolina
 

Jeffrey Weber, M.D., Ph.D.

Director, Donald A. Adam Comprehensive Melanoma Research Center
Senior Member, H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
 

ex-officio Member:

Alison Martin, M.D.

Chief Medical Officer, MRFBC
Washington, D.C.